157 related articles for article (PubMed ID: 22691110)
1. Systemic delivery of atropine sulfate by the MicroDose Dry-Powder Inhaler.
Corcoran TE; Venkataramanan R; Hoffman RM; George MP; Petrov A; Richards T; Zhang S; Choi J; Gao YY; Oakum CD; Cook RO; Donahoe M
J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):46-55. PubMed ID: 22691110
[TBL] [Abstract][Full Text] [Related]
2. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Salbutamol Delivered from the Unit Dose Dry Powder Inhaler: Comparison with the Metered Dose Inhaler and Diskus Dry Powder Inhaler.
Moore A; Riddell K; Joshi S; Chan R; Mehta R
J Aerosol Med Pulm Drug Deliv; 2017 Jun; 30(3):164-172. PubMed ID: 28170282
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic Comparison of a Unit Dose Dry Powder Inhaler with a Multidose Dry Powder Inhaler for Delivery of Fluticasone Furoate.
Mehta R; Moore A; Riddell K; Joshi S; Chan R
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):332-338. PubMed ID: 28463040
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics, Safety, and Tolerability of a New Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate Diskus(®) in Healthy Adults.
Vutikullird AB; Gillespie M; Song S; Steinfeld J
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):207-14. PubMed ID: 26624976
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of bronchodilator response to inhaled albuterol delivered by metered-dose inhaler and a novel dry powder inhaler.
Kemp JP; Hill MR; Vaughan LM; Meltzer EO; Welch MJ; Ostrom NK
Ann Allergy Asthma Immunol; 1997 Oct; 79(4):322-6. PubMed ID: 9357377
[TBL] [Abstract][Full Text] [Related]
8. Comparative absorption of inhaled and intramuscularly administered atropine.
Harrison LI; Smallridge RC; Lasseter KC; Goldlust MB; Shamblen EC; Gam VW; Chang SF; Kvam DC
Am Rev Respir Dis; 1986 Aug; 134(2):254-7. PubMed ID: 3740650
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies.
Kerwin EM; Taveras H; Iverson H; Wayne D; Shah T; Lepore MS; Miller DS
Clin Drug Investig; 2016 Jan; 36(1):55-65. PubMed ID: 26541599
[TBL] [Abstract][Full Text] [Related]
10. Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler.
Srichana T; Juthong S; Thawithong E; Supaiboonpipat S; Soorapan S
Clin Respir J; 2016 Jan; 10(1):74-82. PubMed ID: 25043636
[TBL] [Abstract][Full Text] [Related]
11. Comparative absorption of atropine from a metered-dose inhaler and an intramuscular injection.
Kehe CR; Lasseter KC; Miller NC; Wick KA; Shamblen EC; Ekholm BP; Sandahl JH; Chang SF; Goldlust MB; Kvam DC
Ther Drug Monit; 1992 Apr; 14(2):132-4. PubMed ID: 1585397
[TBL] [Abstract][Full Text] [Related]
12. Inhalation of a dry powder ciprofloxacin formulation in healthy subjects: a phase I study.
Stass H; Nagelschmitz J; Willmann S; Delesen H; Gupta A; Baumann S
Clin Drug Investig; 2013 Jun; 33(6):419-27. PubMed ID: 23605507
[TBL] [Abstract][Full Text] [Related]
13. The ELLIPTA® Dry Powder Inhaler: Design, Functionality, In Vitro Dosing Performance and Critical Task Compliance by Patients and Caregivers.
Grant AC; Walker R; Hamilton M; Garrill K
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):474-85. PubMed ID: 26372466
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of the oximes HI 6 and HLö 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors.
Spöhrer U; Thiermann H; Klimmek R; Eyer P
Arch Toxicol; 1994; 68(8):480-9. PubMed ID: 7802588
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of fluticasone propionate multidose, inhalation-driven, novel, dry powder inhaler versus a prevailing dry powder inhaler and a metered-dose inhaler.
Gillespie M; Song S; Steinfeld J
Allergy Asthma Proc; 2015; 36(5):365-71. PubMed ID: 26314817
[TBL] [Abstract][Full Text] [Related]
16. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
[TBL] [Abstract][Full Text] [Related]
17. Inhaled micronized crystalline human insulin using a dry powder inhaler: dose-response and time-action profiles.
Rave K; Nosek L; Heinemann L; Gonzales C; Ernest CS; Chien J; Muchmore D
Diabet Med; 2004 Jul; 21(7):763-8. PubMed ID: 15209771
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects.
Kosoglou T; Hubbell J; Kantesaria B; Hanson ME; Cutler DL
Clin Pharmacol Drug Dev; 2014 May; 3(3):229-34. PubMed ID: 27128613
[TBL] [Abstract][Full Text] [Related]
19. Clinical and bioavailability studies of sublingually administered atropine sulfate.
Rajpal S; Ali R; Bhatnagar A; Bhandari SK; Mittal G
Am J Emerg Med; 2010 Feb; 28(2):143-50. PubMed ID: 20159382
[TBL] [Abstract][Full Text] [Related]
20. Rapid and complete bioavailability of antidotes for organophosphorus nerve agent and cyanide poisoning in minipigs after intraosseous administration.
Murray DB; Eddleston M; Thomas S; Jefferson RD; Thompson A; Dunn M; Vidler DS; Clutton RE; Blain PG
Ann Emerg Med; 2012 Oct; 60(4):424-30. PubMed ID: 22738685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
